Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

DOXAZOSIN IMPURITY D CRS (15 MG)

DOXAZOSIN IMPURITY D CRS (15 MG)

NA

DISCOVER
DOXAZOSIN IMPURITY F CRS (15 MG)

DOXAZOSIN IMPURITY F CRS (15 MG)

23680-84-4

DISCOVER
DOXAZOSIN MESILATE CRS (60 MG)

DOXAZOSIN MESILATE CRS (60 MG)

77883-43-3

DISCOVER
DIGOXIN FOR PEAK IDENTIFICATION CRS (20 MG)

DIGOXIN FOR PEAK IDENTIFICATION CRS (20 MG)

20830-75-5

DISCOVER
IOTROLAN CRS (100 MG)

IOTROLAN CRS (100 MG)

79770-24-4

DISCOVER
FEBANTEL CRS (120 MG)

FEBANTEL CRS (120 MG)

58306-30-2

DISCOVER
FLUCONAZOLE CRS (50 MG)

FLUCONAZOLE CRS (50 MG)

86386-73-4

DISCOVER
FLUCONAZOLE FOR PEAK IDENTIFICATION CRS (10 MG)

FLUCONAZOLE FOR PEAK IDENTIFICATION CRS (10 MG)

86386-73-4

DISCOVER
CLOBETASOL PROPIONATE CRS (55MG)

CLOBETASOL PROPIONATE CRS (55MG)

25122-46-7

DISCOVER
OXACILLIN FOR PEAK IDENTIFICATION CRS (10 MG)

OXACILLIN FOR PEAK IDENTIFICATION CRS (10 MG)

7240-38-2

DISCOVER
VECURONIUM BROMIDE CRS (10 MG)

VECURONIUM BROMIDE CRS (10 MG)

50700-72-6

DISCOVER
MIDAZOLAM IMPURITY C CRS (0.08 MG)

MIDAZOLAM IMPURITY C CRS (0.08 MG)

NA

DISCOVER